152 related articles for article (PubMed ID: 37042723)
1. Intestinal uric acid excretion contributes to serum uric acid decrease during acute gout attack.
Zhao T; Cao L; Lin C; Xu R; Du X; Zhou M; Yang X; Wan W; Zou H; Zhu X
Rheumatology (Oxford); 2023 Dec; 62(12):3984-3992. PubMed ID: 37042723
[TBL] [Abstract][Full Text] [Related]
2. Soluble uric acid increases PDZK1 and ABCG2 expression in human intestinal cell lines via the TLR4-NLRP3 inflammasome and PI3K/Akt signaling pathway.
Chen M; Lu X; Lu C; Shen N; Jiang Y; Chen M; Wu H
Arthritis Res Ther; 2018 Feb; 20(1):20. PubMed ID: 29415757
[TBL] [Abstract][Full Text] [Related]
3. ABCG2 dysfunction increases serum uric acid by decreased intestinal urate excretion.
Takada T; Ichida K; Matsuo H; Nakayama A; Murakami K; Yamanashi Y; Kasuga H; Shinomiya N; Suzuki H
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):275-81. PubMed ID: 24940679
[TBL] [Abstract][Full Text] [Related]
4. The Anti-Inflammatory and Uric Acid Lowering Effects of Si-Miao-San on Gout.
Cao L; Zhao T; Xue Y; Xue L; Chen Y; Quan F; Xiao Y; Wan W; Han M; Jiang Q; Lu L; Zou H; Zhu X
Front Immunol; 2021; 12():777522. PubMed ID: 35069549
[TBL] [Abstract][Full Text] [Related]
5. Estradiol regulates intestinal ABCG2 to promote urate excretion via the PI3K/Akt pathway.
Liu L; Zhao T; Shan L; Cao L; Zhu X; Xue Y
Nutr Metab (Lond); 2021 Jun; 18(1):63. PubMed ID: 34144706
[TBL] [Abstract][Full Text] [Related]
6. Differential gene expression of ABCG2, SLC22A12, IL-1β, and ALPK1 in peripheral blood leukocytes of primary gout patients with hyperuricemia and their comorbidities: a case-control study.
Natsuko PD; Laura SC; Denise CC; Lucio VR; Carlos AS; Fausto SM; Ambar LM
Eur J Med Res; 2022 May; 27(1):62. PubMed ID: 35505381
[TBL] [Abstract][Full Text] [Related]
7. Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.
Toyoda Y; Pavelcová K; Bohatá J; Ješina P; Kubota Y; Suzuki H; Takada T; Stiburkova B
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669292
[TBL] [Abstract][Full Text] [Related]
8. ABCG2 as a therapeutic target candidate for gout.
Fujita K; Ichida K
Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
[TBL] [Abstract][Full Text] [Related]
9. Sirt1 ameliorates monosodium urate crystal-induced inflammation by altering macrophage polarization via the PI3K/Akt/STAT6 pathway.
Liu L; Zhu X; Zhao T; Yu Y; Xue Y; Zou H
Rheumatology (Oxford); 2019 Sep; 58(9):1674-1683. PubMed ID: 31106362
[TBL] [Abstract][Full Text] [Related]
10. Renal excretion is a cause of decreased serum uric acid during acute gout.
Zhao T; Lv X; Cao L; Guo M; Zheng S; Xue Y; Zou H; Wan W; Zhu X
Int J Rheum Dis; 2018 Sep; 21(9):1723-1727. PubMed ID: 30345643
[TBL] [Abstract][Full Text] [Related]
11. Paeonia × suffruticosa Andrews leaf extract and its main component apigenin 7-O-glucoside ameliorate hyperuricemia by inhibiting xanthine oxidase activity and regulating renal urate transporters.
Zhang Y; Li Y; Li C; Zhao Y; Xu L; Ma S; Lin F; Xie Y; An J; Wang S
Phytomedicine; 2023 Sep; 118():154957. PubMed ID: 37478683
[TBL] [Abstract][Full Text] [Related]
12. Hyperuricemia in acute gastroenteritis is caused by decreased urate excretion via ABCG2.
Matsuo H; Tsunoda T; Ooyama K; Sakiyama M; Sogo T; Takada T; Nakashima A; Nakayama A; Kawaguchi M; Higashino T; Wakai K; Ooyama H; Hokari R; Suzuki H; Ichida K; Inui A; Fujimori S; Shinomiya N
Sci Rep; 2016 Aug; 6():31003. PubMed ID: 27571712
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of ABCG2-mediated extra-renal urate excretion in hemodialysis patients.
Ohashi Y; Toyoda M; Saito N; Koizumi M; Kanai G; Komaba H; Kimura M; Wada T; Takahashi H; Takahashi Y; Ishida N; Kakuta T; Fukagawa M; Ichida K
Sci Rep; 2023 Jan; 13(1):93. PubMed ID: 36639673
[TBL] [Abstract][Full Text] [Related]
14. Amelioration effects of α-viniferin on hyperuricemia and hyperuricemia-induced kidney injury in mice.
Guo XL; Gao YY; Yang YX; Zhu QF; Guan HY; He X; Zhang CL; Wang Y; Xu GB; Zou SH; Wei MC; Zhang J; Zhang JJ; Liao SG
Phytomedicine; 2023 Jul; 116():154868. PubMed ID: 37209608
[TBL] [Abstract][Full Text] [Related]
15. Urate Transporter ABCG2 Function and Asymptomatic Hyperuricemia: A Retrospective Cohort Study of CKD Progression.
Ohashi Y; Kuriyama S; Nakano T; Sekine M; Toyoda Y; Nakayama A; Takada T; Kawamura Y; Nakamura T; Matsuo H; Yokoo T; Ichida K
Am J Kidney Dis; 2023 Feb; 81(2):134-144.e1. PubMed ID: 35810827
[TBL] [Abstract][Full Text] [Related]
16. The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion.
Hoque KM; Dixon EE; Lewis RM; Allan J; Gamble GD; Phipps-Green AJ; Halperin Kuhns VL; Horne AM; Stamp LK; Merriman TR; Dalbeth N; Woodward OM
Nat Commun; 2020 Jun; 11(1):2767. PubMed ID: 32488095
[TBL] [Abstract][Full Text] [Related]
17. The Role of the Intestine in the Development of Hyperuricemia.
Yin H; Liu N; Chen J
Front Immunol; 2022; 13():845684. PubMed ID: 35281005
[TBL] [Abstract][Full Text] [Related]
18. ABCG2 is a high-capacity urate transporter and its genetic impairment increases serum uric acid levels in humans.
Nakayama A; Matsuo H; Takada T; Ichida K; Nakamura T; Ikebuchi Y; Ito K; Hosoya T; Kanai Y; Suzuki H; Shinomiya N
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1091-7. PubMed ID: 22132962
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of mechanism underlying hypouricemic effect of glucosyl hesperidin.
Ota-Kontani A; Hirata H; Ogura M; Tsuchiya Y; Harada-Shiba M
Biochem Biophys Res Commun; 2020 Jan; 521(4):861-867. PubMed ID: 31711647
[TBL] [Abstract][Full Text] [Related]
20. ABCG2 dysfunction increases the risk of renal overload hyperuricemia.
Matsuo H; Takada T; Nakayama A; Shimizu T; Sakiyama M; Shimizu S; Chiba T; Nakashima H; Nakamura T; Takada Y; Sakurai Y; Hosoya T; Shinomiya N; Ichida K
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):266-74. PubMed ID: 24940678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
